Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

This Antibiotic Play May Be The Trius Of 2014
Seeking Alpha
Friday, November 15, 2013 - 4:29pm
tags:
Trius, antibiotics, Cempra, Solithromycin
3 Profitable Pharmaceutical Stocks To Consider As Congress Debates Drug Bill
TheStreet.com
Friday, November 15, 2013 - 11:54am
tags:
Forest Labs, Allergan, Bristol-Myers Squibb
What the End of Bristol-Myers Squibb Royalties Means for Repligen
Motley Fool
Friday, November 15, 2013 - 11:51am
tags:
Repligen, Bristol-Myers Squibb, Orencia
Isis Earns $5 Million in Milestone Payment from GSK for Advancement of ISIS-GSK4 Rx
Yahoo
Friday, November 15, 2013 - 11:34am
tags:
Isis Pharmaceuticals, GSK, antisense, ISIS-GSK4Rx
China's Pharma Potential Diminished
Bloomberg Businessweek
Friday, November 15, 2013 - 11:32am
tags:
China
OncoMed initiates second Phase 1b clinical trial of vantictumab
Yahoo/AP
Friday, November 15, 2013 - 11:25am
tags:
OncoMed, vantictumab, non-small cell lung cancer
Why GeoVax Is Different In The HIV/AIDS Vaccine Space
Seeking Alpha
Friday, November 15, 2013 - 11:24am
tags:
GeoVax Labs, HIV, AIDS, vaccines
Why AstraZeneca plc Will Be One Of 2013's Winners
Motley Fool
Friday, November 15, 2013 - 10:22am
tags:
AstraZeneca
Endologix: Is Covidien Itching To Buy?
Seeking Alpha
Friday, November 15, 2013 - 10:11am
tags:
Covidien, devices, Endologix, M&A
Cadence: Best Case Outcome On Ofirmev Patent Litigation
Seeking Alpha
Friday, November 15, 2013 - 9:55am
tags:
Cadence Pharmaceuticals, Ofirmev, patents, Exela Pharma Sciences
Summer Street doubts FDA will approve Xiaflex on December 6 PDUFA
The Fly on the Wall
Friday, November 15, 2013 - 9:54am
tags:
FDA, Xiaflex, Peyronie's Disease
Eteplirsen in Question: Hope for Sarepta
Motley Fool
Friday, November 15, 2013 - 9:51am
tags:
eteplirsen, Sarepta Therapeutics, Duchenne Muscular Dystrophy
Profit bonanza eludes companies chasing obesity business
Reuters
Friday, November 15, 2013 - 9:42am
tags:
obesity, diabetes, Novo Nordisk, Arena Pharmaceuticals, Vivus
Merck KGaA invests $107 million in China drug plant
Yahoo/Reuters
Friday, November 15, 2013 - 9:39am
tags:
Merck KGaA, drug manufacturing, China
AstraZeneca, Generic Drugmakers Face Class Action on Nexium
Bloomberg/Businessweek
Friday, November 15, 2013 - 9:36am
tags:
generics, Class Action Lawsuit, AstraZeneca, Nexium, Teva
BioMarin's Morquio A drug confers "modest" benefit -FDA review
Yahoo/Reuters
Friday, November 15, 2013 - 9:04am
tags:
Biomarin, Morquio A Syndrome, FDA, Vimizim
Kimberly-Clark Plans to Spin Off Health-Care Business
Bloomberg
Friday, November 15, 2013 - 8:49am
tags:
devices, Kimberly-Clark
Baxter, Cell Therapeutics announce collaboration to develop pacritinib
Yahoo/Fly on the Wall
Friday, November 15, 2013 - 8:43am
tags:
Baxter International, pacritinib, Cell Therapeutics, JAK2/FLT3 inhibitors, solid tumors, myelofibrosis
Zafgen drug helps patients lose up to 24 pounds
Yahoo/Reuters
Friday, November 15, 2013 - 8:42am
tags:
Zafgen, beloranib, obesity
DARA: Building An Oncology And Supportive Care Specialty Pharma
Yahoo/Zacks.com
Friday, November 15, 2013 - 8:40am
tags:
DARA Biosciences, oncology, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.